default author photo

Guanglin Lei

Government of the People's Republic of China - Department of Hepatobiliary Surgery

Beijing

China

  • Government of the People's Republic of China - Department of Hepatobiliary Surgery

SCHOLARLY PAPERS

1

DOWNLOADS

61

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Anti-HBV Therapy in Hepatocellular Carcinoma May Affect the Symptoms of SARS-CoV-2 Infection

Number of pages: 19 Posted: 22 May 2023
Yan Xu, Fang Sun, Chaohui Xiao, Guanglin Lei, Jitao Wang, Mingguang Wang, Zikang Li, Zhaohai Wang and Rong Liu
Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Hepatobiliary Surgery, Government of the People's Republic of China - Department of Hepatobiliary Surgery, Xingtai People's Hospital - Department of Hepatobiliary Surgery, Xingtai People's Hospital - Department of Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery and Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery
Downloads 61 (951,658)

Abstract:

Loading...

SARS-CoV-2, hepatocellular carcinoma, anti-HBV therapy, IL-2, T cell, prognosis